11.04.2011 • News

Merck, Sun Pharma Eye India Marketing Tie-Up

U.S. drugmaker Merck & Co is close to striking a marketing alliance with Sun Pharmaceutical Industries for the Indian market, the Mint reported on Monday.

The partnership between Sun and MSD Pharmaceuticals, the Indian arm of the U.S. drugmaker, could either be a marketing joint venture or a co-marketing tie-up, the newspaper said citing sources it did not name.

An announcement was likely on Monday, it said, adding officials at both the companies declined comment.

In January, German drugmaker Bayer signed an agreement with India's Cadila Healthcare to set up a joint venture to market products locally.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.